Now showing items 1-6 of 6

    • Fear of diseases among people over 50 years of age : a survey 

      Bystad, Martin Kragnes; Grønli, Ole Kristian; Lilleeggen, Camilla; Aslaksen, Per M. (Journal article; Tidsskriftartikkel; Peer reviewed, 2016-12-11)
      The aim of this study was to investigate the association between well-known diseases and fear of them in individuals over 50 years of age. Information on the fear of diseases can be relevant for both public health information purposes and clinical setting diagnostics. However, very few studies have investigated the fear of diseases in individuals over the age of 50. We used an electronic survey ...
    • High-Definition Transcranial Direct Current Stimulation Improves Delayed Memory in Alzheimer’s Disease Patients: A Pilot Study Using Computational Modeling to Optimize Electrode Position 

      Rasmussen, Ingrid Daae; Boayue, Nya Mehnwolo; Mittner, Matthias; Bystad, Martin Kragnes; Grønli, Ole Kristian; Vangberg, Torgil Riise; Csifcsak, Gabor; Aslaksen, Per M. (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-09-14)
      Background: The optimal stimulation parameters when using transcranial direct current stimulation (tDCS) to improve memory performance in patients with Alzheimer’s disease (AD) are lacking. In healthy individuals, inter-individual differences in brain anatomy significantly influence current distribution during tDCS, an effect that might be aggravated by variations in cortical atrophy in AD ...
    • How can placebo effects best be applied in clinical practice? A narrative review 

      Bystad, Martin Kragnes; Bystad, Camilla; Wynn, Rolf (Journal article; Tidsskriftartikkel; Peer reviewed, 2015-01-29)
      Placebo effects are documented in a number of clinical and experimental studies. It is possible to benefit from placebo effects in clinical practice by using them as effects additive to those of documented and effective treatments. The purpose of this paper is to discuss how doctors and other health workers may benefit from placebo effects within an ethical framework. A narrative review of the ...
    • The relation of hippocampal subfield volumes to verbal episodic memory measured by the California Verbal Learning Test II in healthy adults 

      Aslaksen, Per M; Bystad, Martin Kragnes; Ørbo, Marte; Vangberg, Torgil Riise (Journal article; Tidsskriftartikkel; Peer reviewed, 2018-06-08)
      Total hippocampal volume has previously been shown to correlate with performance on tests for verbal episodic memory. However, there are sparse evidence on how hippocampal subfield volumes are related to verbal episodic memory in healthy adults. The present study investigated the association between volumes of separate hippocampal subfields and verbal episodic memory performance in healthy volunteers. ...
    • Relaxation techniques as an intervention for chronic pain: A systematic review of randomized controlled trials 

      Vambheim, Sara Magelssen; Kyllo, Tonje; Hegland, Sanne; Bystad, Martin Kragnes (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-08-20)
      Chronic pain increases the risk of sleep disturbances, depression and disability. Even though medical treatments have limited value, the use of prescription-based analgesics have increased over the recent years. It is therefore important to evaluate the effect of non-pharmacological treatments. A systematic search for studies evaluating the effect of relaxation techniques on chronic pain was ...
    • Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer’s disease: a randomized, placebo-controlled trial 

      Bystad, Martin Kragnes; Grønli, Ole Kristian; Rasmussen, Ingrid Daae; Gundersen, Nina; Nordvang, Lene; Wang-Iversen, Henrik A.S.; Aslaksen, Per M. (Journal article; Tidsskriftartikkel; Peer reviewed, 2016-03-23)
      <p><i>Background:</i> The purpose of this study was to assess the efficacy of transcranial direct current stimulation (tDCS) on verbal memory function in patients with Alzheimer’s disease. <p><i>Methods:</i> We conducted a randomized, placebo-controlled clinical trial in which tDCS was applied in six 30-minute sessions for 10 days. tDCS was delivered to the left temporal cortex with 2-mA intensity. ...